Fibroblast/ECM = 3D functional unit
How do units regulate #PancreaticCancer tumorigenesis, immunosuppression & drug responses?
#TumorMicroenvironment
My Tweets!
Data from @RevMedicines at upcoming #ESMOGI26
Safety & efficacy of zoldonrasib (RMC-9805) plus chemotherapy in patients with 1st line RAS G12D metastatic #PancreaticCancer
https://t.co/dzkWOquioh
Did you know that Cancer Research Communications offers a home for high-quality pilot studies, hypothesis-generating work, and stepwise advances? Learn more about @AACR’s #OpenAccess, peer-reviewed journal: https://t.co/tb9cTu0lnE
Today marks 9 years since the enormous loss of our dear friend & colleague Patti @patricia_keely to #PancreaticCancer
The ECM giant who gave us the tumor-associated collagens - TACs signatures
She would have loved to see the @RevMedicines success in launching Ras inhibitors
💜
Check out @RoyNovoselsky and @OfraGolani new paper in @NatureComms: https://t.co/MzM6MnOD4h. We combine image processing and spatial transcriptomics to extract sub-cellular mRNA polarization in tissues. @WeizmannScience.
When you submit to Cancer Research Communications, you’ll benefit from editorial support at every stage, including guidance from professional in-house editors committed to fast decisions. Learn more: https://t.co/U0y1pCMt8E
Please join us in welcoming Dr. Robert A. Winn as Cancer Center Director for Fox Chase Cancer Center.
Guided by a belief in the power of hope, collaboration, and community, Dr. Winn brings a vision for advancing cancer research, care, and impact: https://t.co/GGrrbAuG6S
Researchers at Fox Chase Cancer Center, led by @ednacukierman, PhD, have developed a first-of-its-kind tool to better understand pancreatic cancer by measuring the tumor microenvironment, the biological “neighborhood” surrounding a tumor. Read more: https://t.co/cXgnaJekR9
Top line data from Tango Therapeutics PRMT5 inh (Vopimetostat) plus @RevMedicines Daraxonrasib or Zoldonrasibin 2nd+ line #PancreaticCancer
https://t.co/b0fW4UVIfR
Daraxonrasib (left) and Zoldonrasib (right) combination data. MultiRAS inhibition better than allele specific.
Fox Chase Cancer Center's Andrea Porpiglia, MD, MSc, FACS, and Kelly Filchner, PhD, RN, OCN, CCRC, received a $50,000 grant to study sexual dysfunction in women undergoing rectal cancer treatment, an often-overlooked aspect of survivorship care. Read more: https://t.co/U3RuRJ23OE
Cancer risk rises with age, but research models often don’t reflect it. New findings from Fox Chase presented at the @AACR annual meeting show melanoma spread may peak in middle age and be driven by key immune cells. Read more from @FaneMitchell, PhD: https://t.co/VtNRmNAHee
Last evening we celebrated the installation of Filip Bednar, MD, PhD as the Maud T. Lane Research Professor in Surgical Oncology. A distinguished pancreatic surgeon, brilliant researcher and highly respected teacher and mentor. Congratulations, Dr. Bednar! @Fil_Bednar@timofran1@LyssiotisLab@Pasca_Lab